Palmer joins BMY as CSO

James Palmer joined Bristol-Myers (BMY) as CSO. Prior, he was SVP of new product development at GlaxoSmithKline (GSK; LSE:GSK). Palmer replaces Peter Ringrose, who departed to fulfill "long-term plans...